Live feed08:30:00·46dPRReleasevia QuantisnowAldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye DiseaseByQuantisnow·Wall Street's wire, on your screen.ALDX· Aldeyra Therapeutics Inc.Health Care
